AI Prospecting for Walgreens Boots Alliance

Walgreens Boots Alliance reported fiscal year 2024 earnings, highlighting a 6.0% increase in fourth-quarter sales to $37.5 billion, despite a $978 million operating loss due to non-cash goodwill impairments. The company announced a footprint optimization program involving the closure of approximately 1,200 stores over the next three years, starting with 500 in fiscal 2025. The quarterly dividend remains at 25 cents per share, paid on December 12, 2024[1][2][4].

Walgreens Boots Alliance exceeded its fiscal 2024 targets, achieving $1 billion in cost savings, a $600 million reduction in capital expenditures, and a $500 million improvement in working capital management. The company also reported a significant increase in U.S. Healthcare segment adjusted EBITDA of $442 million[2].

Walgreens Boots Alliance announced a settlement of a shareholder derivative action and provided notice of pending and proposed settlements on November 29, 2024. The company also faces a $2.7 billion tax claim from the IRS and is considering the full sale of VillageMD due to potential overpayment of nearly $6 billion for the clinics[4][5].